Cargando…
Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma
Pulmonary sarcomatoid carcinoma (PSC) is a rare and aggressive subtype of non-small-cell lung cancer (NSCLC). Here, we present information on the clinicopathologic characteristics and clinical outcomes of this type of cancer. Clinicopathologic data from 55 patients treated at a single cancer center...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113756/ https://www.ncbi.nlm.nih.gov/pubmed/35592676 http://dx.doi.org/10.3389/fonc.2022.833486 |
_version_ | 1784709638034292736 |
---|---|
author | Sun, Jiachun Jiang, Zhiyi Shan, Tanyou Yang, Ruina Kong, Dejiu Rui, Junshuai Li, Xinyang Kong, Guoqiang Chang, Baoping |
author_facet | Sun, Jiachun Jiang, Zhiyi Shan, Tanyou Yang, Ruina Kong, Dejiu Rui, Junshuai Li, Xinyang Kong, Guoqiang Chang, Baoping |
author_sort | Sun, Jiachun |
collection | PubMed |
description | Pulmonary sarcomatoid carcinoma (PSC) is a rare and aggressive subtype of non-small-cell lung cancer (NSCLC). Here, we present information on the clinicopathologic characteristics and clinical outcomes of this type of cancer. Clinicopathologic data from 55 patients treated at a single cancer center from January 2011 to December 2018 were retrospectively analyzed. The patients were mostly male (76.4%), with a median age of 66 years and a history of smoking (54.5%). Most had symptoms, and about 60% presented with locally advanced or metastatic disease at diagnosis. Of the 55 cases, 21 were diagnosed by surgical resection. Pleomorphic cancer was the most common subtype (58.1%). With a median follow-up period of 13.2 months, the average survival time of the patients was 16.1 months, and the median survival time was 12 months. The overall survival rates for 1, 2, and 3 years were 52.7%, 18.2%, and 9.1%, respectively. Univariate analysis showed that prognosis of the patients was influenced by tumor size, T stage, metastatic status, and surgery (p < 0.05). Multivariate analysis showed that T stage (p = 0.034) was an independent prognostic factor. There are few reports on the natural history of PSC, and its clinicopathological characteristics remain unclear. Herein, a retrospective review 55 individuals with PSC found that T stage was an independent predictor of survival. Surgical resection was associated with better prognosis. |
format | Online Article Text |
id | pubmed-9113756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91137562022-05-18 Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma Sun, Jiachun Jiang, Zhiyi Shan, Tanyou Yang, Ruina Kong, Dejiu Rui, Junshuai Li, Xinyang Kong, Guoqiang Chang, Baoping Front Oncol Oncology Pulmonary sarcomatoid carcinoma (PSC) is a rare and aggressive subtype of non-small-cell lung cancer (NSCLC). Here, we present information on the clinicopathologic characteristics and clinical outcomes of this type of cancer. Clinicopathologic data from 55 patients treated at a single cancer center from January 2011 to December 2018 were retrospectively analyzed. The patients were mostly male (76.4%), with a median age of 66 years and a history of smoking (54.5%). Most had symptoms, and about 60% presented with locally advanced or metastatic disease at diagnosis. Of the 55 cases, 21 were diagnosed by surgical resection. Pleomorphic cancer was the most common subtype (58.1%). With a median follow-up period of 13.2 months, the average survival time of the patients was 16.1 months, and the median survival time was 12 months. The overall survival rates for 1, 2, and 3 years were 52.7%, 18.2%, and 9.1%, respectively. Univariate analysis showed that prognosis of the patients was influenced by tumor size, T stage, metastatic status, and surgery (p < 0.05). Multivariate analysis showed that T stage (p = 0.034) was an independent prognostic factor. There are few reports on the natural history of PSC, and its clinicopathological characteristics remain unclear. Herein, a retrospective review 55 individuals with PSC found that T stage was an independent predictor of survival. Surgical resection was associated with better prognosis. Frontiers Media S.A. 2022-05-03 /pmc/articles/PMC9113756/ /pubmed/35592676 http://dx.doi.org/10.3389/fonc.2022.833486 Text en Copyright © 2022 Sun, Jiang, Shan, Yang, Kong, Rui, Li, Kong and Chang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Sun, Jiachun Jiang, Zhiyi Shan, Tanyou Yang, Ruina Kong, Dejiu Rui, Junshuai Li, Xinyang Kong, Guoqiang Chang, Baoping Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma |
title | Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma |
title_full | Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma |
title_fullStr | Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma |
title_full_unstemmed | Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma |
title_short | Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma |
title_sort | characteristics and prognostic analysis of 55 patients with pulmonary sarcomatoid carcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113756/ https://www.ncbi.nlm.nih.gov/pubmed/35592676 http://dx.doi.org/10.3389/fonc.2022.833486 |
work_keys_str_mv | AT sunjiachun characteristicsandprognosticanalysisof55patientswithpulmonarysarcomatoidcarcinoma AT jiangzhiyi characteristicsandprognosticanalysisof55patientswithpulmonarysarcomatoidcarcinoma AT shantanyou characteristicsandprognosticanalysisof55patientswithpulmonarysarcomatoidcarcinoma AT yangruina characteristicsandprognosticanalysisof55patientswithpulmonarysarcomatoidcarcinoma AT kongdejiu characteristicsandprognosticanalysisof55patientswithpulmonarysarcomatoidcarcinoma AT ruijunshuai characteristicsandprognosticanalysisof55patientswithpulmonarysarcomatoidcarcinoma AT lixinyang characteristicsandprognosticanalysisof55patientswithpulmonarysarcomatoidcarcinoma AT kongguoqiang characteristicsandprognosticanalysisof55patientswithpulmonarysarcomatoidcarcinoma AT changbaoping characteristicsandprognosticanalysisof55patientswithpulmonarysarcomatoidcarcinoma |